Search | MakeMyFriends

Ashpak Bahamad added blog Other
2025-12-05 06:47:24 -

Gene Editing market Investment Opportunities, Future Trends, Business Demand and Growth Forecast 2032
Gene Editing Market to Surge Past USD 40 Billion by 2034, Driven by Rising Demand for Precision Medicine and Agricultural Innovation The global gene editing market, valued at around USD 9.30 billion in 2024, is forecast to grow to approximately USD 40.10 billion by 2034, fueled by increasing prevalence of genetic disorders, advancing gene-editing technologies such as CRISPR/Cas, and...

0 Comments 0 Shares 267 Views 0 Reviews

Please log in to like, share and comment!
Anuj Mrfr added blog Health
2026-04-21 12:18:38 -

Induced Pluripotent Stem Cells Market: How Is Gene Editing Enhancing iPSC Therapeutic Potential?
iPSC and gene editing integration — the combination of iPSC reprogramming with CRISPR-Cas9, base editing, prime editing, and other precision gene editing tools creating the dual technology platform enabling both personalized disease correction and universal donor engineering — represents one of the most commercially powerful technology convergences in modern biotechnology, with the...

0 Comments 0 Shares 89 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Health
2025-12-31 10:23:50 -

Forecasting the Billion-Dollar Future: Genomic Investments Through 2032
The financial trajectory of the biotechnology sector is increasingly tied to the success of genomic engineering. Financial analysts have noted that the "rare disease" market is no longer a niche segment but a central pillar of pharmaceutical strategy. Large-cap pharmaceutical companies are aggressively acquiring smaller biotech startups to secure intellectual property and established delivery...

0 Comments 0 Shares 234 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Health
2025-12-31 10:51:40 -

Predicting the 2030 Genomic Landscape: A Decade of CRISPR Innovation
The trajectory of genomic medicine is pointing toward a future where "one-and-done" cures are the standard rather than the exception. As we project the next ten years of development, the focus is shifting toward in-vivo editing—delivering CRISPR components directly into the human body. This would eliminate the need for expensive and complex ex-vivo procedures where cells are removed,...

0 Comments 0 Shares 289 Views 0 Reviews

Please log in to like, share and comment!